Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Thermo Scientific™ Solid tumor: AcroMetrix Oncology Hotspot Control (IVD, CE-IVD)
GSA_VA

Catalog No. 23279193
Click to view available options
Quantity:
3 x 25 μL

Assess day-to-day test variation of somatic mutation panels with the Thermo Scientific™ AcroMetrix™ Oncology Hotspot Control, which is for In Vitro Diagnostic Use.

Assess day-to-day test variation of somatic mutation panels. Intended for use with next generation sequencing (NGS) assays designed to identify somatic mutations in DNA from human samples. For In Vitro Diagnostic Use.

  • Multiple variant types to capture the diversity of somatic cancer mutation types
  • 500+ clinically relevant variants allow detection of multiple targets with NGS in a single reaction
  • IVD labeled enables use in clinical diagnostics
  • Variant frequency near LOD for test method development and validation

FAQs

This product(s) resides on a Fisher Scientific GSA or VA contract. If you are viewing this page as a nonregistered user, the price(s) displayed is List Price. To view your GSA or VA contract pricing, log in using your account number, or become a registered user by contacting one of our Customer Service teams. You can also view your contract price by searching for this item(s) on GSA Advantage. To place an order, contact Fisher Scientific Customer Service.

TRUSTED_SUSTAINABILITY

Specifications

Type Oncology Hotspot Control
Packaging 3 x 25µL
Quantity 3 x 25 μL
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.